FIELD: biochemical methods. SUBSTANCE: invention provides new "affine ligand/matrix" conjugates containing ligand bound to matrix support optionally through spacer group between matrix and ligand and to preparation thereof and their application in purification of protein materials such as, for example, immunoglobulins, insulin, factor VII, or human growth factor or its analogs, derivatives and fragments, and their precursors. EFFECT: enabled manufacture of inexpensive and stable affine columns. 83 cl, 12 tbl, 182 ex
Title | Year | Author | Number |
---|---|---|---|
AFFINE LIGANDS, BINDINBG ANTIBODIES | 2005 |
|
RU2440582C2 |
GLYCEROL LINKED PEGYLATED SUGARS AND GLYCOPEPTIDES | 2007 |
|
RU2460543C2 |
REGENERATION OF CHROMATOGRAPHIC STATIONARY PHASE | 2004 |
|
RU2350945C2 |
INSULIN DERIVATIVE, SOLUBLE PROLONGED PHARMACEUTICAL COMPOSITION, METHOD OF PROLONGATION OF HYPOGLYCAEMIC EFFECT IN TREATMENT OF DIABETIC PATIENTS | 1994 |
|
RU2164520C2 |
LIPOPHILIC DERIVATIVES OF PEPTIDE HORMONES | 1996 |
|
RU2171261C2 |
METHOD FOR PREPARATION OF INSULIN COMPOUNDS | 2002 |
|
RU2376379C2 |
INSULIN PURIFICATION | 2012 |
|
RU2603752C2 |
METHOD OF PREPARING HETEROGENEOUS POLYPEPTIDE IN YEAST SACCHAROMYCES CEREVISIAE | 1990 |
|
RU2194758C2 |
DERIVATIVES OF CONDENSED 1,2,4-THIADIAZINE AND CONDENSED 1,4-THIAZINE, THEIR SYNTHESIS AND USING | 1997 |
|
RU2199542C2 |
DERIVATIVES OF PYRIDO-1,2,4-THIADIAZINE OR PYRIDO-1,4-THIAZINE, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF MANIFESTATION OF ACTIVITY INHIBITING INSULIN SECRETION | 1997 |
|
RU2193564C2 |
Authors
Dates
2001-10-27—Published
1996-09-19—Filed